28 research outputs found
685 DETECTION OF FACTORS AFFECTING EARLY BLADDER RECURRENCE AFTER NEPHROURETERECTOMY IN PATIENTS WITH N0M0 UPPER URINARY TRACT UROTHELIAL CARCINOMA
Renal Oncocytoma with Intracytoplasmic Lumina: A Case Report with Ultrastructural Findings of "Oncoblasts"
Rapid progression of mucinous tubular and spindle cell carcinoma of the kidney without sarcomatoid changes: A case report
MP7-11 PROGNOSTIC IMPACT OF NUCLEOPHOSMIN/B23 EXPRESSION IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC) IN PATIENTS UNDERGOING RADICAL NEPHROURETERECTOMY (RNU)
2068 PREDICTION OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY USING A PERITUMORAL LYMPHATIC VESSEL DENSITY PARAMETER IN BIOPSY SPECIMENS FROM PATIENTS WITH LOCALIZED PROSTATE CANCER
Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy
Prognostic Factors for Upper Urinary Tract Urothelial Carcinoma after Nephroureterectomy
<i>Introduction:</i> The purpose of this study was to evaluate prognostic factors for patients with upper urinary tract urothelial carcinoma (UUT-UC) after nephroureterectomy and to seek a better way of finding more favorable clinical results for these patients. <i>Patients and Methods:</i> We retrospectively reviewed the medical records of 121 UUT-UC patients who underwent a nephroureterectomy at our institution, and analyzed the prognostic significance of various clinicopathological parameters for progression-free and disease-specific survival rates by using univariate and multivariate analysis. <i>Results:</i> A Cox proportional hazards model showed that extravesical tumor recurrence after surgery was an independent prognostic factor for disease-specific survival (p < 0.0001). An additional model showed that lymphovascular invasion (LVI) was one of the independent predictors of lower extravesical-recurrence-free survival rates (p = 0.0004). Our final finding was that pathological tumor stage and positive surgical margin were significantly associated with the presence of LVI (p < 0.0001 and p = 0.0029, respectively). <i>Conclusions:</i> We conclude that there is a high possibility of LVI in patients with large tumors. Our findings should be helpful in terms of determining whether or not to perform neoadjuvant chemotherapy for patients with large tumors, given the fact that we frequently find a severe reduction in renal function after nephroureterectomy.</jats:p
